Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > the protocol change notice from Health Canada

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon Oct 28, 2023 5:50pm

190 Views

Post# 35705900

RE:RE:the protocol change notice from Health Canada

I'm thinking so Legit,

I'm betting the PR on the 16th was a trial balloon for whatever data changes the FDA wanted? The way the data was presented was different. Now they just contact the sites and re tally the data in the proper format, and re-submit if it is a no brained maybe the FDA beats the 60 day clock and we all get a nice Xmas gift. I guess it depends on who's desk it drops on.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario